These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8164303)

  • 1. Effect of protein-calorie malnutrition on methotrexate pharmacokinetics.
    Charland SL; Bartlett D; Torosian MH
    JPEN J Parenter Enteral Nutr; 1994; 18(1):45-9. PubMed ID: 8164303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A significant methotrexate-glutamine pharmacokinetic interaction.
    Charland SL; Bartlett DL; Torosian MH
    Nutrition; 1995; 11(2):154-8. PubMed ID: 7647480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nutritional status on the hepatobiliary excretion of methotrexate in the rat.
    Grossie VB; Loo TL
    Cancer Treat Rep; 1983 Mar; 67(3):253-7. PubMed ID: 6403239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of etodolac on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Anaya JM; Fabre D; Bressolle F; Bologna C; Alric R; Cocciglio M; Dropsy R; Sany J
    J Rheumatol; 1994 Feb; 21(2):203-8. PubMed ID: 8182625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.
    Iven H; Bartels H
    Cancer Treat Rep; 1985; 69(7-8):825-32. PubMed ID: 4016793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of nutritional depletion and repletion on plasma methotrexate pharmacokinetics.
    Mihranian MH; Wang YM; Daly JM
    Cancer; 1984 Nov; 54(10):2268-71. PubMed ID: 6488146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate in rabbits.
    Iven H; Brasch H; Engster J
    Cancer Chemother Pharmacol; 1985; 15(2):115-20. PubMed ID: 4017160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clearance studies of methotrexate and 7-hydroxy-methotrexate in rabbits after multiple-dose infusion.
    Chen ML; Chiou WL
    J Pharmacokinet Biopharm; 1983 Oct; 11(5):515-27. PubMed ID: 6668557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and elimination of 7-hydroxymethotrexate in the rat in vivo after methotrexate administration.
    Bremnes RM; Slørdal L; Wist E; Aarbakke J
    Cancer Res; 1989 May; 49(9):2460-4. PubMed ID: 2706634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 7-hydroxy-methotrexate and methotrexate in the rat.
    Slørdal L; Jaeger R; Kjaeve J; Aarbakke J
    Pharmacol Toxicol; 1988 Aug; 63(2):81-4. PubMed ID: 3186623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacokinetics and toxicity after high-dose methotrexate treatments in children with acute lymphoblastic leukemia.
    Csordas K; Hegyi M; Eipel OT; Muller J; Erdelyi DJ; Kovacs GT
    Anticancer Drugs; 2013 Feb; 24(2):189-97. PubMed ID: 23187460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of methotrexate toxicity with improved nutritional status in tumor-bearing animals.
    Torosian MH; Mullen JL; Miller EE; Zinnser KR; Buzby GP
    Cancer; 1988 May; 61(9):1731-5. PubMed ID: 3128396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of theophylline in protein-calorie malnutrition.
    Jung D
    Biopharm Drug Dispos; 1985; 6(3):291-9. PubMed ID: 3929852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of acetaminophen in protein-calorie malnutrition.
    Jung D
    J Pharmacol Exp Ther; 1985 Jan; 232(1):178-82. PubMed ID: 3917505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
    Widemann BC; Sung E; Anderson L; Salzer WL; Balis FM; Monitjo KS; McCully C; Hawkins M; Adamson PC
    J Pharmacol Exp Ther; 2000 Sep; 294(3):894-901. PubMed ID: 10945838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of methotrexate and 7-hydroxymethotrexate following infusions of high-dose methotrexate.
    Breithaupt H; Küenzlen E
    Cancer Treat Rep; 1982 Sep; 66(9):1733-41. PubMed ID: 6956440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J; Hak J; Martínková J; Chládek J
    Arzneimittelforschung; 2010; 60(12):769-75. PubMed ID: 21265469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maximum tolerated doses of methotrexate and 7-hydroxy-methotrexate in a model of acute toxicity in rats.
    Fuskevåg OM; Kristiansen C; Lindal S; Aarbakke J
    Cancer Chemother Pharmacol; 2000; 46(1):69-73. PubMed ID: 10912581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly sensitive high-performance liquid chromatographic assay for methotrexate in the presence and absence of anti-methotrexate antibody fragments in rat and mouse plasma.
    Lobo ED; Balthasar JP
    J Chromatogr B Biomed Sci Appl; 1999 Dec; 736(1-2):191-9. PubMed ID: 10676999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.